Biology Reference
In-Depth Information
[110] Norde WJ, Maas F, Hobo W, Korman A, Quigley M, Kester MG, et al. PD-1/PD-L1
interactions contribute to functional T-cell impairment in patients who relapse with
cancer after allogeneic stem cell transplantation. Cancer Res 2011;71:5111-22.
[111] Spaapen RM, de Kort RA, van den OK, van Elk M, Bloem AC, Lokhorst HM, et al. Rapid
identification of clinical relevant minor histocompatibility antigens via genome-wide
zygosity-genotype correlation analysis. Clin Cancer Res 2009;15:7137-43.
[112] James E, Chai JG, Dewchand H, Macchiarulo E, Dazzi F, Simpson E. Multiparity induces
priming to male-specific minor histocompatibility antigen, HY, in mice and humans.
Blood 2003;102:388-93.
[113] Verdijk RM, Kloosterman A, Pool J, van de KM, Naipal AM, van Halteren AG, et al. Preg-
nancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications
for stem cell transplantation and immunotherapy. Blood 2004;103:1961-4.
[114] Mommaas B, Stegehuis-Kamp JA, van Halteren AG, Kester M, Enczmann J, Wernet P,
et al. Cord blood comprises antigen-experienced T cells specific for maternal minor
histocompatibility antigen HA-1. Blood 2005;105:1823-7.
[115] van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A, et al.
Naturally acquired tolerance and sensitization to minor histocompatibility antigens in
healthy family members. Blood 2009;114:2263-72.
[116] Mutis T, Goulmy E. Hematopoietic system-specific antigens as targets for cellular im-
munotherapy of hematological malignancies. Semin Hematol 2002;39:23-31.
[117] Kohrt HE, Muller A, Baker J, Goldstein MJ, Newell E, Dutt S, et al. Donor immunization
with WT1 peptide augments antileukemic activity after MHC-matched bone marrow
transplantation. Blood 2011;118:5319-29.
[118] Perez-Simon JA, Caballero D, ez-Campelo M, Lopez-Perez R, Mateos G, Canizo C, et al.
Chimerism and minimal residual disease monitoring after reduced intensity condition-
ing (RIC) allogeneic transplantation. Leukemia 2002;16:1423-31.
[119] Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug
resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma
cell lines. Blood 1999;93:1658-67.
[120] Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, et al. CD4
+
CD25
+
regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-
host disease after bone marrow transplantation. Nat Med 2003;9:1144-50.
[121] Cai J, Lee J, Jankowska-Gan E, Derks R, Pool J, Mutis T, et al. Minor H antigen HA-
1-specific regulator and effector CD8
+
T cells, and HA-1 microchimerism, in allograft
tolerance. J Exp Med 2004;199:1017-23.
58
Search WWH ::
Custom Search